To Enter Japanese Generic Market, Quality Comes First, Experts Tell Indian Drug Makers

MUMBAI - Daiichi Sankyo's acquisition of India's largest generic drug maker Ranbaxy may have been timed to maximize benefits from emerging opportunities in the Japanese generic drug industry